ArticleThe Journal of biological chemistry2013

Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximab.

Shuaiyi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.